C12N 2760/16222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/16222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 182 US grants and 262 published applications in this corpus.
Search patents in C12N- Granted patents
- 182
- Published applications
- 262
- Assignees
- 131
- Inventors
- 453
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 1 |
| 2003 | 3 | 2 |
| 2004 | 1 | 7 |
| 2005 | 3 | 5 |
| 2006 | 1 | 5 |
| 2007 | 3 | 8 |
| 2008 | 5 | 13 |
| 2009 | 9 | 13 |
| 2010 | 2 | 19 |
| 2011 | 8 | 13 |
| 2012 | 8 | 16 |
| 2013 | 12 | 10 |
| 2014 | 11 | 13 |
| 2015 | 12 | 12 |
| 2016 | 14 | 10 |
| 2017 | 5 | 11 |
| 2018 | 5 | 9 |
| 2019 | 12 | 16 |
| 2020 | 8 | 13 |
| 2021 | 6 | 9 |
| 2022 | 13 | 10 |
| 2023 | 7 | 12 |
| 2024 | 8 | 14 |
| 2025 | 9 | 9 |
| 2026 | 2 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Influenza virus vaccines and uses thereof17 Mar 2026US 12,577,279 B2Janssen Vaccines & Prevention B. V.
- Influenza virus-like particle production in plants11 Nov 2025US 12,467,058 B2Aramis Biotechnologies Inc.
- Influenza b virus mutants and uses therefor19 Aug 2025US 12,390,519 B2FluGen, Inc.
- Mosaic influenza virus hemagglutinin polypeptides and uses thereof22 Jul 2025US 12,364,746 B2Icahn School of Medicine at Mount Sinai
- Influenza b virus mutants and uses therefor10 Sep 2026US 2026/0263586 A1FluGen, Inc.
- Nucleic acid influenza vaccines and respiratory virus combination vaccines27 Aug 2026US 2026/0248903 A1ModernaTX, Inc.
- Mosaic influenza virus hemagglutinin polypeptides and uses thereof30 Jul 2026US 2026/0216314 A1Icahn School of Medicine at Mount Sinai
- Compositions and methods for treating viral infections23 Jul 2026US 2026/0209279 A1G Tech Bio LLC
- Influenza b virus vaccines and uses thereof2 Jul 2026US 2026/0183380 A1Janssen Vaccines & Prevention B. V.
Most cited
By later US patents
- Expression of influenza a M2 protein in baculovirus108US 5,290,686 AThe United States of America as represented by the Department of Health and Human Services · 1994
- DNA transfection system for the generation of infectious influenza virus91US 6,951,754 B2St. Jude Children?S Research Hospital · 2005
- Anti-human influenza virus antibody73US 5,589,174 ATakara Shuzo Co., Ltd. · 1996
- Influenza hemagglutinin and neuraminidase variants71US 7,566,458 B2MedImmune, LLC · 2009
- Anti-human influenza virus antibody70US 5,631,350 ATakara Shuzo Co., Ltd. · 1997